デフォルト表紙
市場調査レポート
商品コード
1687541

脱塩・緩衝液交換の市場規模、シェア、成長分析:製品別、手法別、用途別、最終用途別、地域別 - 産業予測、2025年~2032年

Desalting and Buffer Exchange Market Size, Share, and Growth Analysis, By Product (Cassettes & Cartridges, Membrane Filters), By Technique (Filtration, Chromatography), By Application, By End-Use, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 198 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
脱塩・緩衝液交換の市場規模、シェア、成長分析:製品別、手法別、用途別、最終用途別、地域別 - 産業予測、2025年~2032年
出版日: 2025年03月17日
発行: SkyQuest
ページ情報: 英文 198 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

脱塩・緩衝液交換の市場規模は2023年に13億4,000万米ドルと評価され、2024年の14億7,000万米ドルから2032年までには31億6,000万米ドルに成長し、予測期間(2025年~2032年)のCAGRは10.0%で成長する見通しです。

世界の脱塩・緩衝液交換市場は、バイオ医薬品の研究および生産における需要の増加によって大きく成長しています。この拡大に拍車をかけている主な要因には、タンパク質精製技術に対する意識の高まりや生物製剤の採用増加などがあります。クロマトグラフィーやろ過方法における技術革新は、市場機会をさらに拡大します。これらの技術の主な消費者は製薬とバイオテクノロジー部門であり、市場開拓の加速に役立っています。北米と欧州は研究インフラが確立されているため現在優位を占めているが、アジア太平洋地域は大幅な成長の可能性を秘めています。脱塩技術、スケーラビリティソリューション、緩衝液交換プロセスの持続可能性における継続的な進歩は、業界プレイヤー間の戦略的パートナーシップとともに、競合情勢を形成する注目すべき動向です。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主要な市場の考察

  • 主要な成功要因
  • 競合の程度
  • 主要な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 規制情勢

脱塩・緩衝液交換市場規模:製品別・CAGR(2025年~2032年)

  • 市場概要
  • カセット・カートリッジ
  • メンブレンフィルター
  • スピンコラム
  • フィルタープレート
  • キット
  • その他の消耗品

脱塩・緩衝液交換市場規模:手法別・CAGR(2025年~2032年)

  • 市場概要
  • 濾過
  • クロマトグラフィー
  • 降水量

脱塩・緩衝液交換市場規模:用途別・CAGR(2025年~2032年)

  • 市場概要
  • バイオプロセス用途
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • 診断用途

脱塩・緩衝液交換市場規模:最終用途別・CAGR(2025年~2032年)

  • 市場概要
  • 製薬・バイオテクノロジー企業
  • 契約調査機関(CRO)
  • 学術調査機関
  • 診断検査室

脱塩・緩衝液交換市場規模・CAGR(2025年~2032年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022年~2024年)

主要企業プロファイル

  • Thermo Fisher Scientific(USA)
  • Sartorius AG(Germany)
  • Merck KGaA(Germany)
  • Danaher Corporation(USA)
  • Agilent Technologies(USA)
  • Repligen Corporation(USA)
  • GE HealthCare Technologies(USA)
  • Bio-Works Technologies(Sweden)
  • Norgen Biotek Corp(Canada)
  • Bio-Rad Laboratories(USA)
  • Avantor, Inc.(USA)
  • Pall Corporation(USA)
  • Waters Corporation(USA)
  • EMD Millipore(USA)
  • Tosoh Bioscience(Japan)
  • PerkinElmer(USA)
  • Shimadzu Corporation(Japan)
  • Lonza Group(Switzerland)

結論と提言

目次
Product Code: SQMIG30B2031

Desalting and Buffer Exchange Market size was valued at USD 1.34 billion in 2023 and is poised to grow from USD 1.47 billion in 2024 to USD 3.16 billion by 2032, growing at a CAGR of 10.0% during the forecast period (2025-2032).

The global Desalting and Buffer Exchange market is experiencing significant growth, largely driven by the increasing demand in biopharmaceutical research and production. Key factors fueling this expansion include heightened awareness of protein purification techniques and the rising adoption of biologics. Technological innovations in chromatography and filtration methods further enhance market opportunities. The primary consumers of these technologies are the pharmaceutical and biotechnology sectors, which are instrumental in accelerating market development. North America and Europe currently dominate due to established research infrastructures, while the Asia-Pacific region presents substantial growth potential. Ongoing advancements in desalting technologies, scalability solutions, and sustainability in buffer exchange processes are noteworthy trends, alongside strategic partnerships among industry players shaping the competitive landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Desalting And Buffer Exchange market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Desalting And Buffer Exchange Market Segments Analysis

Global Desalting and Buffer Exchange Market is segmented by Product, Technique, Application, End-Use and region. Based on Product, the market is segmented into Cassettes & Cartridges, Membrane Filters, Spin Columns, Filter Plates, Kits and Other Consumables. Based on Technique, the market is segmented into Filtration, Chromatography and Precipitation. Based on Application, the market is segmented into Bioprocess Applications, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Diagnostic Applications. Based on End-Use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Desalting And Buffer Exchange Market

The growing demand for biopharmaceuticals, such as monoclonal antibodies and therapeutic proteins, serves as a significant catalyst for the desalting and buffer exchange market. As the biopharmaceutical sector experiences continuous growth, the necessity for efficient purification methods increases, with desalting and buffer exchange being pivotal in this process. These advanced purification techniques are becoming essential in meeting the rising requirements of the industry, ensuring the production of high-quality biopharmaceuticals. Consequently, the emphasis on developing effective and sustainable purification solutions will drive the market for desalting and buffer exchange, aligning with the broader trends within the biopharmaceutical landscape.

Restraints in the Desalting And Buffer Exchange Market

A significant restraint in the Desalting and Buffer Exchange market is the high initial costs associated with the adoption of advanced desalting and buffer exchange technologies. The capital-intensive requirements for acquiring and integrating these sophisticated systems can pose a challenge, particularly for smaller research labs or organizations with constrained financial resources. These elevated expenses may deter potential users from investing in essential equipment, thus limiting market growth and making it difficult for smaller entities to compete with larger counterparts that can more easily absorb these costs. Consequently, these financial barriers restrict broader access to advanced desalting solutions in the marketplace.

Market Trends of the Desalting And Buffer Exchange Market

The Desalting and Buffer Exchange market is currently experiencing significant growth driven by the rising adoption of automated and high-throughput technologies. These advancements enhance process efficiency, reduce manual labor, and minimize processing times, particularly crucial for large-scale biopharmaceutical manufacturing. Additionally, the industry is increasingly focusing on sustainable practices, with a notable shift towards the use of biodegradable materials in desalting and buffer exchange technologies. This trend aligns with the global push for environmental responsibility, reflecting a broader consciousness among biopharmaceutical companies to embrace eco-friendly solutions while improving operational efficiencies in their manufacturing processes.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Desalting and Buffer Exchange Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Cassettes & Cartridges
  • Membrane Filters
  • Spin Columns
  • Filter Plates
  • Kits
  • Other Consumables

Global Desalting and Buffer Exchange Market Size by Technique & CAGR (2025-2032)

  • Market Overview
  • Filtration
  • Chromatography
  • Precipitation

Global Desalting and Buffer Exchange Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Bioprocess Applications
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Diagnostic Applications

Global Desalting and Buffer Exchange Market Size by End-Use & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Diagnostic Laboratories

Global Desalting and Buffer Exchange Market Size & CAGR (2025-2032)

  • North America (Product, Technique, Application, End-Use)
    • US
    • Canada
  • Europe (Product, Technique, Application, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Technique, Application, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Technique, Application, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Technique, Application, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Thermo Fisher Scientific (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Repligen Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE HealthCare Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Works Technologies (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Norgen Biotek Corp (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pall Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waters Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMD Millipore (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tosoh Bioscience (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations